Jayne & Graham supporting iron fran

Benali’s Iron Fran
3 May 2019

Jayne & Graham supporting iron fran

profile picture
Jayne Lycett

Total raised


+ £115.00 Gift Aid

240 Complete
240% of £200.00 target

Donating through this page is simple, fast and totally secure. Your details are safe with Cancer Research UK

Benali’s Iron Fran – 7 Iron Mans In 7 Days

Francis Benali is a former Southampton FC player who launched a £1m fundraising mission for Cancer Research UK through a series of gruelling physical challenges. The first took place in 2014 and saw Benali run a 1,000 miles between the Premier League football grounds in England. Two years later he completed his second ultra-challenge, running and cycling between Premier League and Championship grounds.

Now he’s about to take on his third and final challenge in a bid to hit his £1m target by undertaking a superhuman seven Ironman distance triathlons on seven consecutive days between 29th April – 5th May 2019 – that’s a 2.4 mile swim, 112 mile bike ride, 26.2 mile run over a 1,000 miles in one week!

Latest updates





+£75.00 Gift Aid

Wendy Travers




Bev Gray



+£5.00 Gift Aid

What an inspirational man he is and well done you for supporting xx


Ali Morgan



+£2.50 Gift Aid

Well done for keeping this going.


Sarah Bookham



+£2.50 Gift Aid

You're going to smash it!!


Paul Stubbington



+£5.00 Gift Aid

Good luck Jayne and well done on the progress with your running. Copythorne 10k next!

Total raised£480.00



With Cancer Research UK Giving Pages more of the money raised goes towards beating cancer sooner. Aside from the credit and debit card fees, every penny donated goes to Cancer Research UK.

All donations made to this page will automatically be transferred to Cancer Research UK.


Childhood cancer

Each year, around 1,500 children are diagnosed with cancer in the UK. Thanks to major advances in research, around three-quarters of children with cancer now survive. Help Cancer Research UK discover better and kinder treatments for all cancers and to continue to improve overall survival for childhood cancer.